Advertisement

Topics

Search Results for "Abbott Dartford Murex Biotech Ltd"

20:55 EDT 22nd July 2017 | BioPortfolio

Matching Channels

Urokinase Abbott

Biotech jobs

The Top 10 Medical Device Companies

Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in ...

Czech Republic

Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

#jobs #lifescience Proclinical: Technical Services Team Leader

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Proclinical: Technical Services Team Leader . Highly Competitive: Proclinical...

Abbott Expands Diagnostics Business with $5.3 Billion Acquisition of Alere

ABBOTT PARK, Ill. and WALTHAM, Mass., April 14, 2017 /PRNewswire/ — Abbott (NYSE: ABT) and Alere Inc. (NYSE: ALR) announced today that the companies have agreed to amend the existing terms of t...

Abbott Agrees To Buy Alere At Lower Price

NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT) and Alere Inc. (ALR) said Friday that they have agreed to amend the existing terms of their agreement for Abbott's acquisition of Alere. Additio...

New Abbott diabetes deal is a “missed opportunity” for DexCom

Abbott struck a deal with Bigfoot Medical by which the latter will use Abbott’s glucose sensing technology to develop an artificial

Abbott Laboratories’ bittersweet week

Despite the week ending on a high note for Abbott Laboratories with an amended $5.3 billion deal to buy Alere, a warning letter from the U.S. Food and Drug Administration drew attention to is

Abbott to Present at Leerink Swann 2012 Global Healthcare Conference

ABBOTT PARK, Ill., Feb. 1, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the Leerink Swann 2012 Global Healthcare Conference on Wednesday, Feb. 15, 2012. Thomas C. Freyman, executive vice pr...

Abbott And Bigfoot Collaborate To Develop Breakthrough Diabetes Tech

NORTH CHICAGO (dpa-AFX) - Abbott (ABT) and Bigfoot Biomedical said that they have entered into an agreement to develop and commercialize diabetes management systems, integrating Abbott's FreeStyle...

Abbott Declares 374th Consecutive Quarterly Dividend

ABBOTT PARK, Ill., June 9, 2017 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 26.5 cents per share. This marks the 374th cons...

Matching PubMed Articles

Comparison of Abbott RealTime genotype II, GeneMatrix restriction fragment mass polymorphism, and Sysmex HISCL HCV Gr assays for hepatitis C virus genotyping.

Hepatitis C virus (HCV) genotype is a predictive marker for treatment response. We sequentially evaluated the performances of two nucleic acid amplification tests (NAATs) and one serology assay for HC...

Off they go: Single-use Technology in Future Production BioTech 2016 Conference at ZHAW Waedenswil.

"Keep up with today's single-use technology standard but also remain one step ahead" - that could have been the motto of the BioTech 2016 conference at ZHAW Waedenswil on September 5 and 6, which brou...

Simultaneous confidence bands for log-logistic regression with applications in risk assessment.

In risk assessment, it is often desired to make inferences on the low dose levels at which a specific benchmark risk is attained. Applications of simultaneous hyperbolic confidence bands for low-dose ...

Acknowledgement to referees.

Performance characteristics of finger-stick dried blood spots (DBS) on the determination of human immunodeficiency virus (HIV) treatment failure in a pediatric population in Mozambique.

Quantitative plasma viral load (VL) at 1000 copies /mL was recommended as the threshold to confirm antiretroviral therapy (ART) failure by the World Health Organization (WHO). Because of ongoing chall...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement